Greggory Warren

We do not anticipate changes to our moat rating or our fair value estimate as a result of the change of leadership.

Insurance gains offset slightly weaker operating results for the wide-moat firm.

Nothing alters our long-term expectations, but we have made some valuation changes.

Positive flows and market gains lift assets under management to a new record.

The stock's the cheapest we can remember seeing in a number of years.

We are leaving our fair value estimate in place for the wide-moat firm.

Wide-moat BlackRock and T. Rowe may not be the cheapest, but they're the best.

Firms face headwinds as balance of power changes toward investors.

First-quarter revenue increased 3.8% to $60.7 billion, more or less in line with our forecast.

Berkshire Hathaway puts some cash to work with a $10 billion pledge.

The Kraft Heinz impairment and equity market sell-off hurt the wide-moat firm, but we're leaving our fair value estimate in place.

Acquisitions, investments, share repurchases, or dividends are some options.

The firm also increased its stake in JPMorgan Chase and other financials.

With Bill Gross' fund performance faltering again in 2018, we weren't surprised by the announcement and are leaving our fair value estimate in place.

The company's size and scale, strength of brands, and consistent record are strong advantages.

Berkshire holdings Wells Fargo and Goldman Sachs are currently trading at steep enough discounts to recommend.

The Oracle of Omaha and his lieutenants initiated positions in JPMorgan Chase and Oracle, among others, last quarter.

We are leaving our fair value estimate in place after slightly better than expected results.

Narrow-moat Invesco acquired the firm for $5.7 billion, higher than estimates, to be paid entirely in stock.

It was a solid quarter from the asset manager, and the company is well positioned despite some institutional outflows from riskier asset classes.

U.S. asset managers' valuations are depressed, but we see some opportunity.

With both firms being viewed as average when it comes to performance and product offering, we'd view this as more of a pricey scale move.

We have one upgrade but more downgrades as well as fair value estimate cuts.

The wide-moat firm also purchased additional shares of Goldman Sachs and US Bancorp during the second quarter.

Our fair value estimate for Berkshire is unchanged after earnings were basically in line with our expectations.

The wide-moat firm made large additions to its stakes in Monstanto and Teva Pharmaceuticals and sold a significant slug of Versik Analytics shares.

Looking past accounting changes, some weakness at BNSF and the lapping of the AIG retroactive insurance deal penned last year were the major stories in first quarter earnings.

Increased volatility and poor equity market performance in the first quarter didn't stop this wide-moat firm from gathering assets.

Invesco still offers the best relative value, but BlackRock is starting to look attractive too.

Hurricanes had a heavy impact on Berkshire’s operating earnings, but book value continued to grow.

Invesco piques our interest at today's prices.

Positive flows, market gains, and acquisitions should drive assets under management higher.

We recently raised our fair value estimate for the wide-moat firm to $550.

Adding Ajit Jain and Greg Abel to Berkshire's board doesn't make the succession plan any clearer, but it adds credence to our long-held belief that these managers are the leading candidates to replace Buffett.

Our fair value estimate is unchanged after a rough third quarter.